PEPTIDE RESEARCH TOPIC

CJC-1295 Research Peptide

Explore CJC-1295 terminology, DAC and no-DAC distinctions, research context, comparisons, and handling information.

TOPIC OVERVIEW

About CJC-1295

Molecular design

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone designed for prolonged activity.

  • The Drug Affinity Complex, or DAC, enables covalent association with circulating albumin and extends exposure.
  • CJC-1295 without DAC and modified GRF 1-29 are often used as market labels, but they should not be assumed to be the same molecule as DAC-containing CJC-1295.

GHRH signaling

CJC-1295 acts through the GHRH receptor on pituitary somatotroph cells.

  • Early controlled studies in healthy adults measured sustained changes in growth hormone and IGF-1 while preserving pulsatile GH secretion.
  • Research questions include duration, albumin binding, endocrine markers, sequence identity, stability, and comparisons with ghrelin-receptor agonists.
  • The exact sequence and conjugation state determine which evidence is relevant.

Evidence and naming limits

Human evidence is limited to small early studies and does not establish broad clinical use.

  • CJC-1295 is not generally approved as a therapeutic medicine.
  • Online “DAC” and “no-DAC” labels require analytical confirmation because naming practices are inconsistent across suppliers.
Topics covered
  • GHRH analog terminology
  • DAC and no-DAC distinctions
  • sequence verification
  • storage and stability
  • purity and supplier documentation
Common names and related terms: cjc-1295, cjc 1295, cjc1295, cjc-1295 dac, cjc-1295 no dac
CJC-1295 KNOWLEDGE ARTICLESPage 12 of 25
02
KNOWLEDGE ARTICLE

Sermorelin vs CJC-1295 No DAC: Key Differences

Sermorelin vs CJC-1295 no DAC compared: half-life, dosing, cost, and research results, plus what US buyers should know before choosing either peptide.

↗
03
KNOWLEDGE ARTICLE

CJC-1295 Ipamorelin: With DAC or Without DAC?

CJC-1295 ipamorelin with DAC or without? Compare half-life, dosing frequency, and stacking logic so you can choose the right research protocol.

↗
06
KNOWLEDGE ARTICLE

CJC-1295 No DAC vs Sermorelin: Key Differences

CJC-1295 No DAC vs sermorelin: compare half-life, dosing, IGF-1 effects, and research status so you can see how these two peptides often differ.

↗
07
KNOWLEDGE ARTICLE

CJC 1295 Ipamorelin Peptide Benefits Explained

CJC 1295 ipamorelin peptide benefits may include natural growth hormone release, better sleep, and recovery support. Learn what research shows and safety notes.

↗
09
KNOWLEDGE ARTICLE

CJC-1295 Ipamorelin Dosage: How Much to Take

CJC-1295 and ipamorelin how much to take: typical research dose ranges, injection timing, cycle length, and safety notes for this peptide stack.

↗
11
KNOWLEDGE ARTICLE

CJC-1295 Long-Term Side Effects: What to Know

CJC-1295 long-term side effects are not well studied in humans. Learn what research and user reports suggest, plus safety steps to discuss with a doctor.

↗
14
KNOWLEDGE ARTICLE

CJC-1295 With DAC or Without: Key Differences

CJC-1295 with DAC or without DAC changes half-life, dosing, and side effects. Compare the two forms, typical research doses, and safety facts.

↗